Life Sciences » Drug Delivery

Found 17 technologies within Drug Delivery RSS ATOM

Nanofiber-based immunotherapeutic drug delivery specifically targeted to the atherosclerotic niche

18-0152 – A nanodrug delivery system has been developed which precisely targets controlled immunotherapeutics to the atherosclerotic niche. This system is comprised of therapeutic peptides tethered to nanofibers which self-assemble from peptide amphiphiles. These complexes are targeted specifically to atherosclerotic lesions. In addition to its specificity, the nanofiber-based delivery system stands... Read More

Light catalyzed radiofluorination

17-0133 – This new method of fluorinating biomolecules for PET imaging and other therapeutic applications is catalyzed by light, making it more adaptable than other fluorination methods. This allows easier fluorination of a broader range of molecules including drugs and proteins and avoids the use of potentially hazardous heavy metals. Advantages:

Methods of Acoustic Measurement and Control of Pharmaceutical Sprays

04-0112 – Researchers at the University of North Carolina at Chapel Hill have developed a means to correlate acoustic measurements to spray formation, using that relationship to characterize output spray behavior. The technology uses real-time algorithms to impart disruptive energy to the orifice delivering the spray, in this way the technology can modulate spray formation with the intent of... Read More

Coated filament for evaporation/condensation aerosol generation of therapeutic agents and methods

04-0113 – Researchers at the University of North Carolina at Chapel Hill have developed an aerosol generator device for the delivery and administration of therapeutic agents to the lungs. The technology provides a tunable delivery method capable of generating aerosols at precise particle sizes and at a wide range of flow rates.

Method for the Inhibition of Anti-PEG Antibodies

18-0025 – A method for inhibiting the action of anti-PEG antibodies (APAs) has been developed, with the goal of enhancing the effectiveness of PEGylated proteins and nanoparticle therapeutics. APAs can be induced by PEGylated therapeutics, or they can be pre-existing due to previous exposure to PEG in everyday hygiene and food products. The presence of circulating APAs can render PEGylated therapeutics... Read More

Nanoparticles for the Codelivery of Cancer Immunotherapeutics

17-0119 – Dual immunotherapy nanoparticles (DINPs) that can simultaneously deliver multiple immunotherapeutics have been synthesized. Emerging evidence suggests that administration of certain immunotherapeutics in combination has a synergistic effect. Specifically, an approach that can block checkpoint inhibitor receptors, like PD1, while activating co-stimulatory receptors, like OX40, is desired. This... Read More

Rapid Method for the Assembly of Nanoparticles with Targeting Ligands

11-0136 – A rapid and universal method for the synthesis of nano- and microparticles bearing targeting ligands (TLs) had been developed. Nano- and microparticles have use in the fields of drug delivery and diagnostics. A drawback to these technologies is the difficulty of incorporating a TL onto the surface of these particles. A TL (antibody, antigen, etc.) is often required to direct the particles to... Read More

Composition of Novel Cationic Nanoparticles for the Delivery of siRNA Therapeutics in Lung Cancer

08-0038 – Cationic nanoparticle formulations have been developed for the delivery of siRNA to tumor cells. siRNA therapeutics are promising treatments for many diseases, but they require delivery vehicles to efficiently transport them to their target cell. We have developed a cationic nanoparticle formulation that efficiently delivers siRNA to H460 human lung carcinoma cells. These nanoparticles were... Read More

Composition and Method for Platelet-Based Drug Delivery

00-0110 – A novel method of drug delivery utilizing rehydrated platelets has been developed. Platelets have long been recognized as potential drug delivery vehicles; however, the need to freshly isolate, modify, and reinfuse them in a short time-span has limited their applicability. Cryopreserved and normally-liquid stored platelets circumvent these problems, but suffer from storage issues and the need... Read More

Use of Tardigrade Proteins to Stabilize Biological Materials, Industrial Enzymes, and Agricultural Products

16-0158 – The instability of many high value industrial enzymes and life saving biologics, including vaccines and protein-based pharmaceuticals, require that such materials be produced, transported and stored under refrigerated conditions, which adds difficulty and expense. Lyophilization is an alternate storage method that allows some pharmaceuticals to be stored at room temperature. Unfortunately,... Read More

Exosomal Drug Delivery for Chemotherapy and CNS Disorders

16-0102 – Novel exosome-based compositions have been developed for the delivery of low molecular weight active ingredients, drugs and macromolecular biotherapeutics to sites of disease associated with inflammation including tumors and the central nervous system. When derived from individual patient exosomes, these vesicles have immune-privileged status which allows them to deliver therapeutic agents to... Read More

Poly-Metformin: A Polymeric Formulation for the Treatment of Metabolic Disorders and Enhanced Gene Delivery

15-0060 – A polymeric formulation of Metformin has been developed. PolyMetformin (PolyMet) has been successfully synthesized through conjugation of linear polyethylenimine (PEI) with dicyandiamide. The delocalization of cationic charges in the biguanide groups of PolyMet reduces the toxicity of PEI both in vitro and in vivo. Furthermore, the polycationic properties of PolyMet permit capture of siRNA... Read More

Next Generation Biomedicine Low Frequency Magnetic Nanoparticles

15-0061 – Novel polymer-coated magnetic nanoparticles (MNP-polymer complexes) have been developed that can be used in a variety of biomedical, therapeutic, and industrial applications. The iron oxide magnetic nanoparticle cores are synthesized by thermal decomposition yielding a tunable, uniform size. These unique polymer coatings have been shown to promote enhanced uptake into tumor and other cells.... Read More

Delivery of Neuroprotective Therapeutic Agents to the CNS

15-0104 – Innovative polymer-based formulations have been developed for delivery of neurotrophins to the brain using peripheral and central administration. The anionic block copolymers are used in charge excess with respect to the neurotrophins, so that neurotrophins and block copolymers form a nanoscale size polyion complex, while the free block copolymers are also present in the formulation. The... Read More

Optimal PEG Coating of Particles for Minimizing Uptake and Clearance of Nanoparticle Therapeutics

13-0118 – Nanoparticles with tunable poly(ethylene glycol) (PEG) grafting have been used to determine optimal PEG coating for minimizing immune uptake and clearance. PEG is widely used to improve nanoparticle retention in circulation. Quantitative measurement of surface PEG grafting is difficult for determining the specific amount needed to coat particles to evade uptake and clearance by immune cells.... Read More

Biodegradable Elastomers for Medical Devices and Drug Delivery

06-0047 – Amorphous, polyester-based elastomers have been developed with tunable thermal and mechanical properties for applications in tissue engineering and drug delivery. Synthetic materials for biological applications must have similar mechanical properties to those of surrounding tissue to minimize irritation. Commonly used polymers suffer from rapid loss of mechanical properties upon degradation... Read More

Decision Support System for Intravenous Insulin Infusion with Cross-Step Estimator of Maintenance Rate

07-0042 – A system for determining an intravenous insulin infusion rate to correct hyperglycemia of a patient Advantages: • Reduces the risk of hyper/hypoglycemia • Allows the user to assign a glycemic target • Controls glycemic variability above the glycemic target by a strategy different from the insulin strategy used to control variability below the glycemic target • Takes into account the... Read More